Mass Spectrometry in Systems Neurosciences
We are a young and highly dynamic team that closely collaborates with the interdisciplinary team of biochemists, cell biologists, bioinformaticians, chemists, and clinicians and uses the latest proteomic approaches and equipment to help fighting diseases
Our group has been established in May 2021 and funded by BMBF (German Federal Ministry of Education and Research). We are part of the research consortium “Clinical Mass Spectrometry Center Munich – CLINSPECT-M” and focus on the development and application of proteomic approaches to disease mechanism and biomarker discovery in the areas of neurosciences and precision medicine. We have access to many state-of-art mass spectrometers (9 orbitrap), automated liquid handling systems, several off-line high-performance liquid chromatographies, etc. Most importantly, we closely collaborate with the interdisciplinary team at TUM (chair of proteomics and bioanalytics and University Hospital rechts der Isar) and Bavarian Center for Biomolecular Mass Spectrometry to address important biological and clinical questions.